Clinical Trials on Relapsed or Refractory Peripheral T-Cell Lymphoma
Total 3284 results
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Sun Yat-sen UniversityRecruitingRelapsed or Refractory Peripheral T-cell LymphomaChina
-
Dizal PharmaceuticalsCompletedRelapsed or Refractory Peripheral T Cell LymphomaKorea, Republic of, United States, China, Australia
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
Great Novel Therapeutics Biotech & Medicals CorporationRecruitingRelapsed or Refractory Peripheral T-cell LymphomaTaiwan
-
Kura Oncology, Inc.CompletedRelapsed or Refractory Peripheral T-Cell LymphomaUnited States, Spain, Korea, Republic of
-
Shanghai YingLi Pharmaceutical Co. Ltd.UnknownRelapsed or Refractory Peripheral T-Cell LymphomaChina
-
Samsung Medical CenterCompletedRelapsed or Refractory Peripheral T-cell LymphomaKorea, Republic of
-
Zhejiang Genfleet Therapeutics Co., Ltd.RecruitingRelapsed or Refractory Peripheral T-cell Lymphoma (PTCL)China
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownRelapsed or Refractory Peripheral T-cell and NK/T-cell LymphomaChina
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Shanxi Province... and other collaboratorsRecruitingPeripheral T Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma | Refractory T-Cell LymphomaChina
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeNot yet recruitingRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaSingapore
-
The Lymphoma Academic Research OrganisationCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaFrance, Belgium
-
Millennium Pharmaceuticals, Inc.CompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
-
Affimed GmbHArtiva Biotherapeutics, Inc.RecruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingRelapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)Japan
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
Daiichi SankyoActive, not recruitingRelapsed/Refractory Peripheral T-Cell Lymphoma | Adult T Cell Leukemia/LymphomaUnited States, Spain, Japan, United Kingdom, Korea, Republic of, France, Italy, Australia, Canada, Germany, Netherlands, Taiwan
-
Mundipharma (China) Pharmaceutical Co. LtdCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed T-Cell LymphomaChina
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Peripheral T-cell LymphomaChina
-
Astex Pharmaceuticals, Inc.Active, not recruitingRelapsed/Refractory Peripheral T-cell LymphomaSpain, United States, Australia, France, United Kingdom, Italy, Poland
-
Sun Yat-sen UniversityNot yet recruitingRelapsed and Refractory Peripheral T-cell LymphomaChina
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...UnknownNon-Hodgkin's Lymphoma | Peripheral T Cell Lymphoma | Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma | Chronic Lymphoblastic LeukemiaChina
-
Legend Biotech USA IncActive, not recruitingT-Cell Lymphoma | Peripheral T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma Recurrent | Peripheral T-Cell Lymphoma RecurrentUnited States
-
Ono Pharmaceutical Co. LtdRecruitingRelapsed or Refractory T Cell LymphomaUnited States
-
Samsung Medical CenterCompletedRelapsed and/or Refractory Cutaneous T-cell LymphomaKorea, Republic of
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
Samsung Medical CenterRecruitingRelapsed and/or Refractory Non-Hodgkin T-cell LymphomaKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMycosis Fungoides | Recurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated... and other conditionsUnited States
-
The First Affiliated Hospital with Nanjing Medical...UnknownRelapse/Refratory Peripheral T Cell LymphomaChina
-
Dana-Farber Cancer InstituteLeadiant Biosciences, Inc.TerminatedT-Cell Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingAnaplastic Large Cell Lymphoma | Recurrent Angioimmunoblastic T-Cell Lymphoma | Recurrent Mycosis Fungoides | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Refractory Anaplastic Large Cell Lymphoma | Subcutaneous... and other conditionsUnited States
-
Fondazione Italiana Linfomi - ETSTerminatedT-Cell Lymphoma Relapsed | T-Cell Lymphoma RefractoryItaly
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedBlastic Plasmacytoid Dendritic Cell Neoplasm | HTLV-1 Infection | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Refractory Angioimmunoblastic T-cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent... and other conditionsUnited States
-
University of Alabama at BirminghamTerminatedAnaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Peripheral T-cell Lymphomas | Adult T-cell Leukemia | Adult T-cell Lymphoma | Peripheral T-cell Lymphoma Unspecified | T/Null Cell Systemic Type | Cutaneous t-Cell Lymphoma With Nodal/Visceral DiseaseUnited States
-
Huazhong University of Science and TechnologyShanghai IASO Biotechnology Co., LtdNot yet recruitingChronic Lymphocytic Leukemia (CLL) | Peripheral T-cell Lymphomas (PTCL) | CD5+ Relapsed/Refractory Hematopoietic Malignancies | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL)
-
Fondazione Italiana Linfomi ONLUSActive, not recruitingRelapsed T-Cell Lymphoma | Refractory T-Cell LymphomaItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Angioimmunoblastic T-Cell Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Refractory Anaplastic... and other conditionsUnited States
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingRefractory T-Cell Lymphoma | T Cell Lymphoma in RelapseChina
-
Kyowa Kirin, Inc.Active, not recruitingCutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma, RelapsedUnited States, United Kingdom, Spain, France, Italy
-
University of BirminghamPfizer; BloodwiseCompletedT-Cell Lymphoma Relapsed | T-Cell Lymphoma RefractoryUnited Kingdom
-
BeiGeneCompletedCutaneous T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Extranodal NK/T-cell Lymphoma, Nasal Type | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Peripheral... and other conditionsChina, Taiwan, Germany, France, Canada, Italy
-
M.D. Anderson Cancer CenterActive, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Recurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma and other conditionsUnited States
-
Yale UniversitySidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massey Cancer CenterWithdrawnLymphoma | Relapsed and Refractory Aggressive B- and T-cell LymphomasUnited States
-
The First Affiliated Hospital of Soochow UniversityAffiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower... and other collaboratorsRecruiting
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States
-
Won Seog KimSanofiRecruitingNatural Killer/T-cell Lymphoma | Relapsed Natural Killer/T-cell Lymphoma | Refractory Natural Killer/T-cell LymphomaKorea, Republic of